Data / Form D filings / VIN-41 Neurexis Therapeutics, LLC
VIN-41 Neurexis Therapeutics, LLC: Form D filing
VIN-41 Neurexis Therapeutics, LLC, a company in Fayetteville, AR, filed a Form D with the SEC in 2023. The latest, on August 15, 2023, reports $20,000 sold of a $500,000 offering to 2 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 535 W. RESEARCH CENTER BLVD, SUITE 135, Fayetteville, AR, 72701
- Phone
- (479) 571-2592
- Industry
- Other
- Entity type
- Limited Liability Company
- Incorporated in
- Arkansas
- Year incorporated
- 2023
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1989984
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Aug 15, 2023 | New notice | $500,000 | $20,000 | $480,000 | 2 | Aug 2, 2023 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Robert Calvin Goforth | Executive Officer | |
| Mark Calvin Wagstaff | Executive Officer |
Other companies in Arkansas that filed recently
- AI Legal Support LLC $25,000 · Oct 28, 2026
- JABNE TabSense, LLC offering · Oct 1, 2026
- NWA Releaf Acquisition Holdings, LLC $2.3 million · Sep 29, 2026
- Restara Medical, Inc. $500,000 · Sep 23, 2026
Every Form D from the week of Aug 14, 2023 · All recent filings in Arkansas · All recent Other filings
Read from SEC EDGAR. Amount sold is what VIN-41 Neurexis Therapeutics, LLC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.